Gsdme — Gasdermin E plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
GSDME (Gasdermin E, also known as DFNA5) is a gene located on chromosome 7p15.3 that encodes the gasdermin E protein. Initially identified as a gene causing autosomal dominant nonsensory hearing loss (DFNA5), GSDME has emerged as a critical player in programmed cell death pathways, particularly pyroptosis, with significant implications for neurodegenerative diseases.
The gene is catalogued as NCBI Gene ID 16857 and OMIM 604717.
GSDME is a member of the gasdermin family of proteins, which play key roles in regulated cell death:
Pyroptosis Execution: GSDME is cleaved by caspase-3 to generate the N-terminal fragment (GSDME-NT) that forms pores in the plasma membrane, executing pyroptotic cell death
Tumor Suppression: GSDME acts as a tumor suppressor; loss-of-function mutations are found in various cancers
Immune Response: Involved in antimicrobial immunity through pyroptotic cell death of infected cells
Hearing Function: DFNA5 mutations cause hearing loss through dominant-negative effects on cochlear hair cells
GSDME is expressed in various brain regions:
DFNA5 was the first loci mapped for autosomal dominant nonsensory hearing loss. The disease-causing mutation is an intronic G to A transition that causes aberrant splicing, leading to a truncated protein.
While GSDME is primarily known for hearing loss, emerging research suggests roles in neurodegeneration:
ALS: GSDME-mediated pyroptosis has been implicated in motor neuron death in ALS
Parkinson's Disease: GSDME activation may contribute to dopaminergic neuron loss through pyroptotic pathways
Stroke/Ischemia: GSDME cleavage contributes to neuronal death following cerebral ischemia
Alzheimer's Disease: Evidence for GSDME involvement in amyloid-beta-induced cell death
Caspase-3 Inhibitors: Preventing GSDME cleavage by inhibiting caspase-3 may protect neurons
Pyroptosis Blockade: Targeting gasdermin pore formation
Gene Therapy: Allele-specific silencing for DFNA5 hearing loss
Van Camp G, et al. Localization of a gene for nonsyndromic hearing loss (DFNA5) to chromosome 7p15. Nature Genetics. 1995.
Rogers C, et al. Cleavage of DFNA5 by caspase-3 during apoptosis. PNAS. 2017.
Croes L, et al. The gasdermin family: emerging players in cancer and neurodegenerative diseases. Molecular Psychiatry. 2019.
Gsdme — Gasdermin E plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gsdme — Gasdermin E has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.